parkinson, Parkinson's research notebook

Six readers

reader	found	score
genetics Open Targets	no genetic evidence; overall 0.21 from other evidence	0.00
cell type Human Protein Atlas	cell type enhanced, including microglia; strongest in choroid plexus epithelial cells	0.75
chemistry Open Targets	hard to drug	0.00
trials ClinicalTrials.gov	no Parkinson's trials on record: an open field	1.00
literature PubMed	1 Parkinson's papers of 46	0.91
pathways Reactome	in no curated pathway	0.00

No case: the score is under the bar. Receipt 1990

receipt 1999: WDFY1 in dopamine neurons, braak

power: full sample -0.19 (p 0.439, n 18), 95% CI -0.61 to +0.30. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: -0.18 (p 0.476, n 18). does not hold up.
composition: dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.19 (p 0.439, n 18). could be the mix.
skeptic: leave-one-out range -0.30 to -0.08, sign flips 0; without severely affected donors -0.19 (p 0.439, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for WDFY1 in dopamine neurons.

case closed: nothing better to follow up.

receipt 1998: WDFY1 in microglia, braak

power: full sample -0.21 (p 0.398, n 18), 95% CI -0.62 to +0.28. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: -0.22 (p 0.379, n 18). does not hold up.
composition: microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: -0.15 (p 0.544, n 18). could be the mix.
skeptic: leave-one-out range -0.33 to -0.10, sign flips 0; without severely affected donors -0.21 (p 0.398, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for WDFY1 in microglia.

case closed: nothing better to follow up.

loading the receipts